NCT05842707View on ClinicalTrials.gov

Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 18, 2023

Primary Completion Date

January 18, 2028

Study Completion Date

January 18, 2029

Conditions
Refractory or Relapsed B-cell Non-Hodgkin Lymphoma
Interventions
DRUG

dualCAR-NK19/70 cell

Given by IV (vein)

Trial Locations (1)

200065

RECRUITING

Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai

All Listed Sponsors
lead

Aibin Liang，MD，Ph.D.

OTHER